Ultragenyx Pharma (RARE) PT Lowered to $59 at Cowen
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $26.49 +0.42%
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
21 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cowen analyst Yaron Werber lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $59.00 (from $62.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Tactical Resources completes Plum merger, set for Nasdaq debut
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
